Norway Buccal Drug Delivery Systems Market Size & Outlook
Norway buccal drug delivery systems market, 2016-2028 (US$M)
Related Markets
Norway buccal drug delivery systems market highlights
- The Norway buccal drug delivery systems market generated a revenue of USD 53.8 million in 2021 and is expected to reach USD 89.4 million by 2028.
- The Norway market is expected to grow at a CAGR of 7.5% from 2022 to 2028.
- In terms of segment, buccal tablets/ lozenges was the largest revenue generating type in 2021.
- Sublingual Films And Wafers is the most lucrative type segment registering the fastest growth during the forecast period.
Buccal drug delivery systems market data book summary
| Market revenue in 2021 | USD 53.8 million |
| Market revenue in 2028 | USD 89.4 million |
| Growth rate | 7.5% (CAGR from 2021 to 2028) |
| Largest segment | Buccal tablets/ lozenges |
| Fastest growing segment | Sublingual Films And Wafers |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sublingual Films And Wafers, Buccal Tablets/ Lozenges, Oral Sprays |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Pfizer Inc, Reckitt Benckiser Group PLC, Catalent Inc, Collegium Pharmaceutical Inc, Cynata Therapeutics Ltd, GlaxoSmithKline Consumer Healthcare (GSK CH India), Generex Biotechnology, ARx, Endo Pharmaceuticals |
Other key industry trends
- In terms of revenue, Norway accounted for 1.7% of the global buccal drug delivery systems market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany buccal drug delivery systems market is projected to lead the regional market in terms of revenue in 2028.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 272.0 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Buccal Drug Delivery Systems Market Scope
Buccal Drug Delivery Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway buccal drug delivery systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to buccal drug delivery systems market will help companies and investors design strategic landscapes.
Buccal tablets/ lozenges was the largest segment with a revenue share of 50.37% in 2021. Horizon Databook has segmented the Norway buccal drug delivery systems market based on sublingual films and wafers, buccal tablets/ lozenges, oral sprays covering the revenue growth of each sub-segment from 2016 to 2028.
Reasons to subscribe to Norway buccal drug delivery systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway buccal drug delivery systems market databook
-
Our clientele includes a mix of buccal drug delivery systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway buccal drug delivery systems market , including forecasts for subscribers. This country databook contains high-level insights into Norway buccal drug delivery systems market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Norway buccal drug delivery systems market size, by type, 2016-2028 (US$M)
Norway Buccal Drug Delivery Systems Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
